Log In
BCIQ
Print this Print this
 

GBR 830

  Manage Alerts
Collapse Summary General Information
Company Glenmark Pharmaceuticals Ltd.
DescriptionTumor necrosis factor (TNF) receptor superfamily member 4 (TNFRSF4; OX40; CD134) antagonist
Molecular Target Tumor necrosis factor (TNF) receptor superfamily member 4 (OX40) (TNFRSF4) (CD134)
Mechanism of ActionOX40 ligand (OX40L) (CD134L) antagonist; Antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today